16:00 – 16:15 Opening & Welcome (LIVE)
- H Einsele (Germany)
- C Chommiene (France)
- J Sierra (Spain)
- AA van de Loosdrecht (the Netherlands)
16:15 - 17:00 Session 1: Leukemia-reactive T cells after allogeneic HCST
LIVE SESSION
16:15 – 16:35 Keynote lecture
Clinical strategies to augment the GvL effect after allo HSCT
S Riddell (United states)
16:35 – 17:00 Q&A discussion
- S Riddell (United States)
- I Jedema (the Netherlands)
- S Mielke (Sweden)
ON-DEMAND LECTURES
Target antigens of GvL
I Jedema (the Netherlands)
Strategies to separate GvL from GvHD
S Mielke (Sweden)
17:00 - 18:00 Session 2: Treatment with innate immune cells (NK, γδ-T cells, Dendritic cells)
LIVE SESSION
17:00 - 17:20 Keynote lecture
NK cells
F Locatelli (Italy)
17:20 - 18:00 Q&A discussion
- F Locatelli (Italy)
- J Martinez (Spain)
- J Kuball (the Netherlands)
- AA van de Loosdrecht (the Netherlands)
ON-DEMAND LECTURES
NK CARs
J Martinez (Spain)
γδ-T cells
J Kuball (the Netherlands)
Dendritic cells in MDS/AML
AA van de Loosdrecht (the Netherlands)
18:00 -18:10 Break
18:10 - 18:55 Satellite symposium
18:55 - 19:15 Break
19:15 - 20:00 Session 3: Immunotherapy and laboratory testing
LIVE SESSION
19:15 - 19:35 Keynote lecture
Immunobiology
TBC
19:35 - 20:00 Q&A discussion
- TBC
- A Beilhack (Germany)
- M Juan (Spain)
ON-DEMAND LECTURES
Targeting tregs for tumor therapy of hematologic malignancies
A Beilhack (Germany)
Monitoring
M Juan (Spain)
20:00 - 20:45 Session 4: Checkpoint blockers
LIVE SESSION
20:00 - 20:20 Keynote lecture
Approved and emerging indications
P Bröckelmann (Germany)
20:20 - 20:45 Q&A discussion
- P Bröckelmann (Germany)
- P Brossart (Germany)
- L Vago (Italy)
ON-DEMAND LECTURES
Mechanism of action
P Brossart (Germany)
Mechanisms of Immune Evasion and Relapse after Allogeneic-HCT
L Vago (Italy)
20:45 - 21:30 Session 5: Other immunotherapies: Antibody, RNA and DNA based
LIVE SESSION
20:45 - 21:05 Keynote lecture
Comparison between bispecific antibodies and CAR T-cells esp. for MM
H Einsele (Germany)
21:05 - 21:30 Q&A discussion
- H Einsele (Germany)
- R Padua (France)
- P Rodriguez Otero (Spain)
ON-DEMAND LECTURES
DNA-based immunotherapy: Mechanism of action
R Padua (France)
New immunotherapeutic strategies in MM. Beyond CAR T-cells
P Rodriguez Otero (Spain)
Back